Log in

Venn Life Sciences Share Forecast, Price & News

GBX 6.85
+0.45 (+7.03 %)
(As of 06/27/2019)
Today's Range
Now: GBX 6.85
50-Day Range N/A
52-Week Range
Now: GBX 6.85
Volume1.03 million shs
Average Volume566,253 shs
Market Capitalization£4.89 million
P/E RatioN/A
Dividend YieldN/A
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling. It also provides clinical trial services comprising clinical feasibility assessment, project management, clinical and medical monitoring, biometrics, biostatistics, data management and databases integration, ISC/IDMC, RTSM, investigator initiated studies, and resourcing and recruitment. In addition, the company offers regulatory affairs and consulting, quality assurance, and legal services, as well as drug development training and courses. The company has a strategic collaboration with Open Orphan DAC for the clinical research and regulatory consulting for companies developing products under the auspices of the various Orphan Drug frameworks. The company was founded in 2012 and is headquartered in Dublin, Ireland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.7 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars

Industry, Sector and Symbol

Industry Medical Care



Sales & Book Value

Annual SalesN/A
Book ValueGBX 15.60 per share



Market Cap£4.89 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 6.85
+0.45 (+7.03 %)
(As of 06/27/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive VENN News and Ratings via Email

Sign-up to receive the latest news and ratings for VENN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Venn Life Sciences (LON:VENN) Frequently Asked Questions

Who are some of Venn Life Sciences' key competitors?

What other stocks do shareholders of Venn Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venn Life Sciences investors own include Nielsen (NLSN), Bank of Hawaii (BOH), BJs Wholesale Club (BJ), Biogen (BIIB), Bank of America (BAC), Arrow Electronics (ARW), Arts-Way Manufacturing (ARTW), Arconic (ARNC), Adomani (ADOM) and Adobe (ADBE).

Who are Venn Life Sciences' key executives?

Venn Life Sciences' management team includes the following people:
  • Mr. Anthony Richardson, CEO, Exec. Director & Company Sec. (Age 55)
  • Dr. Christian Bernard Milla, COO & Director (Age 57)

What is Venn Life Sciences' stock symbol?

Venn Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "VENN."

How do I buy shares of Venn Life Sciences?

Shares of VENN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Venn Life Sciences' stock price today?

One share of VENN stock can currently be purchased for approximately GBX 6.85.

How big of a company is Venn Life Sciences?

Venn Life Sciences has a market capitalization of £4.89 million. Venn Life Sciences employs 157 workers across the globe.

What is Venn Life Sciences' official website?

The official website for Venn Life Sciences is www.vennlifesciences.com.

How can I contact Venn Life Sciences?

Venn Life Sciences' mailing address is 1 Berkeley Street, LONDON, W1J 8DJ, United Kingdom. The company can be reached via phone at +44-28-90737900.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.